0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata relapsed chronic lymphocytic leukemia cll global clinical trials review h1 2018.Your search for "" gave back 1533020 results.
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 Summary According to the recently published report 'Gamma Secretase - Drugs In...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary According to the...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Exportin 1 - Pipeline Review, H2 2019 Summary According to the recently published report 'Exportin 1 - Pipeline Review, H2 2019'; Exportin...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Protein Phosphatase 2A - Pipeline Review, H1 2020 Summary Protein Phosphatase 2A (PP2A or EC 3.1.3.16) pipeline Target constitutes close to 7...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,500.00
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Refractory...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players,...
Catalog:
Global Markets Direct
November 2022
Price: USD 3,500.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Nicotinamide Phosphoribosyltransferase - Pipeline Review, H2 2020 Summary Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2018 Summary According to the recently published report 'Protein Phosphatase...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
